Abstract
Monoclonal antibodies (mAb) induce tumor regression through antibody-dependant cellular cytotoxicity (ADCC). we recently showed that an agonistic anti-CD137 mAb stimulates natural killer (NK) cells which have been activated by a tumor-specifc mAb, resulting in increased ADCC against cancer cells. © 2012 Landes Bioscience.
Cite
CITATION STYLE
APA
Houot, R., Kohrt, H., & Levy, R. (2012). Boosting antibody-dependant cellular cytotoxicity against tumor cells with a CD137 stimulatory antibody. OncoImmunology, 1(6), 957–958. https://doi.org/10.4161/onci.19974
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free